Surgical site infection in liver transplant recipients: Impact of the type of perioperative prophylaxis

Transplantation

Volumn 85, Issue 12, 2008, Pages 1849-1854

  García Prado, María E ^a   Matia, Elisa Cordero ^a   Ciuro, Felipe Pareja ^a   Díez Canedo, Juan Serrano ^a   Sousa Martín, José M ^a   Porras López, Francisco M ^a   De La Casa, Ángel Cantos ^a   Cisneros Herreros, José M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Antibiotic prophylaxis; Liver transplantation; Surgical site infection

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CALCINEURIN INHIBITOR; CEFAZOLIN; CORTICOSTEROID; CYCLOSPORIN A; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; AMOXICILLIN; ANTIINFECTIVE AGENT; CLAVULANIC ACID;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GRAFT RECIPIENT; HOSPITALIZATION; HUMAN; INTENSIVE CARE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PATHOGENESIS; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURGICAL INFECTION; SURVIVAL RATE; COMPARATIVE STUDY; DRUG COMBINATION; LENGTH OF STAY; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY;

ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CEFAZOLIN; CLAVULANIC ACID; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LENGTH OF STAY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND INFECTION;

EID: 49149128469     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181735407     Document Type: Article

References (26)

1. Ayats-Ardite J,Cisneros-Herreros JM, Pérez-Sáenz JL, et al. Evaluació n de las enfermedades infecciosas en el candidato a un trasplante de órgano sólido. Enferm Infecc Microbiol Clin 2002; 20: 448.
2. Mehrabi A, Fonouni H, Wente M, et al. Wound complications following kidney and liver transplantation. Clin Transplant 2006; 20: 97.
3. Losada I, Cuervas-Mons V, Millán I, et al. Infección precoz en el paciente con trasplante hepático: incidencia, gravedad, factores de riesgo y sensibilidad antibió tica de los aislados bacterianos. Enferm Infecc Microbiol Clin 2002; 20: 42.
4. Patel RA, Paya CV. Infections in solid organ transplant recipients. Clin Microbiol Rev 1997; 10: 86.
5. Gislason H, Soreide O, Viste A. Wound complications after major gastrointestinal operations. The surgeon as a risk factor. Dig Surg 1999; 16: 512.
6. Anaya DA, Dellinger EP. The obese surgical patient: A susceptible host for infection. Surg Infect 2006; 7: 473.
7. Mangram AJ, Honra TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 1999; 20: 247.
8. Hollenbeak CS, Alfrey EJ, Sheridan K, et al. Surgical site infection following paediatric liver transplantation: Risks and costs. Transplant Infect Dis 2003; 5: 72.
9. Iinuma Y, Senda K, Fujihara N, et al. Surgical site infection in living-donor liver transplant recipients: A prospective study. Transplantation 2004; 78: 704.
10. Arnow PM, Zachary KC, Thistlethwaite JR, et al. Pathogenesis of early operative site infections after orthotopic liver transplantation. Transplantation 1998; 65: 1500.
11. Hollenbeak CS, Alfrey EJ, Souba WW. The effect of surgical site infections on outcomes and resource utilization after liver transplantation. Surgery 2001; 130: 388.
12. Whiting JF, Rossi SJ, Hanto DW. Infectious complications after OKT3 induction in liver transplantation. Liver Transpl Surg 1997; 3: 563.
13. Barie PS, Eachempati SR. Surgical site infections. Surg Clin North Am 2005; 85: 1115.
14. Nichols RL. Preventing surgical site infections:Asurgeon's perspective. Emerg Infect Dis 2001; 7: 220.
15. Conti F, Morelon E, Calmus Y. Immunosuppressive therapy in liver transplantation. J Hepatol 2003; 39: 664.
16. Fung J, Kelly D, Kadry Z, et al. Immunosuppression in liver transplantation: Beyond calcineurin inhibitors. Liver Transp 2005; 11: 267.
17. Echániz A, Pita S, Otero A, et al. Incidencia, factores de riesgo e influencia sobre la supervivencia de las complicaciones infecciosas en el trasplante hepático. Enferm Infecc Microbiol Clin 2003; 21: 224.
18. Kusne S, Dummer JS, Singh N, et al. Infections after liver transplantation: An analysis of 101 consecutive cases. Medicine 1988; 67: 132.
19. George DL, Arnow PM, Fox AS, et al. Bacterial infection as a complication of liver transplantation: Epidemiology and risk factors. Rev Infect Dis 1991; 13: 387.
20. Colonna JO, Winston DJ, Brill JE, et al. Infectious complications in liver transplantation. Arch Surg 1988; 123: 360.
21. Wade JJ, Ronaldo N, Hayllar K, et al. Bacterial and fungal infections after liver transplantation: An analysis of 284 patients. Hepatology 1995; 21:1328.
22. Rodríguez-Baño J, Navarro MD, Romero L, et al. Bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli in the CTX-M era: A new clinical challenge. Clin Infect Dis 2006; 43: 1407.
23. Rodríguez-Baño J, Paterson DL. A change in the epidemiology of infections due to extended-spectrum β-lactamase-producing organisms. Clin Infect Dis 2006; 42: 935.
24. Piazzese E, Montalti R, Beltempo P, et al. Incidence, predisposing factors, and results of surgical treatment of incisional hernia after orthotopic liver transplantation. Transplant Proc 2004; 36: 3097.
25. Martin M, Kusne S, Alesiani M, et al. Infections after liver transplantation: Risk factors and prevention. Transplant Proc 1991; 23: 1929.
26. Singh N, Gayowski T, Wagener M, et al. Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants. Transplantation 1994; 58: 774.